| SpectraBase Spectrum ID |
JGgqCJMVCNs |
| Name |
1-(2-Benzylaminoethyl)-4-benzylpiperazine |
| Classification |
Piperazine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
309.220497881 u |
| Formula |
C20H27N3 |
| InChI |
InChI=1S/C20H27N3/c1-3-7-19(8-4-1)17-21-11-12-22-13-15-23(16-14-22)18-20-9-5-2-6-10-20/h1-10,21H,11-18H2 |
| InChIKey |
JKIDTOZGYQEUIZ-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
309.457 g/mol |
| Nominal Mass |
309 u |
| Quality |
986 |
| Retention Index |
2536 |
| SMILES |
C(N1CCN(CC1)CCNCC1=CC=CC=C1)C=1C=CC=CC1 |
| SPLASH |
splash10-000f-7900000000-6959bf2f868c236f6eda |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Piperazine,1-(2-benzylaminoethyl)-4-benzyl
N-benzyl-2-(4-benzylpiperazin-1-yl)ethan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_010972 |
